Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by
A Matched Control Study of Treatment Outcome in Young Patients With Squamous Cell Carcinoma of the Head and Neck
β Scribed by Hendrik P. Verschuur; Jonathan C. Irish; Brian O'Sullivan; Christopher Goh; Patrick J. Gullane; Melania Pintilie
- Book ID
- 110079900
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 843 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
## Abstract ## Background Positron emission tomography (PET) provides metabolic information of tissues in vivo. The purpose of this study was to assess the value of PET with 2β[^18^ F] fluoroβ2βdeoxyβDβglucose (FDG) in prediction of therapy outcome (tumor response, survival, and locoregional contr
## Abstract ## BACKGROUND. Basaloid squamous cell carcinoma (BSCC) is an uncommon, highβgrade variant of squamous cell carcinoma (SCC) of the head and neck. Its poorer prognosis compared with common SCC remains controversial. The authors investigated the outcomes of patients with BSCC who received